乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Nephrology >

Diabetes

News, opinions and meeting coverage in nephrology.

<乌鸦传媒>ACP: What's New in mHealth

Do apps promoting weight loss and heart health really work?

<乌鸦传媒>Post-Bariatric Hypoglycemia Prevented Through Novel Glucagon Pump

In small study, novel system used CGM with investigational liquid treatment

<乌鸦传媒>Beta-Cells Improved After Two Most Popular Bariatric Surgeries

Similar short-term improvements after Roux-en-Y, sleeve gastrectomy

<乌鸦传媒>ECC Roundup: Breast Conservation Benefit Varies by Age

And other reports from the European Cancer Congress

<乌鸦传媒>FDA Warns on MRI in Patients with Implantable Pumps

Medication, mechanical issues may follow exposure

<乌鸦传媒>Oral Treatment for T2D Tied to Renal Protection

SGLT2 inhibitor shows favorable effect on eGFR

<乌鸦传媒>U.S. Obesity Crisis: Is the Wrong Omega-X Mix Responsible?

Ratio of omega-6 to omega-3 in Western diet is 16:1

<乌鸦传媒>Switching GLP-1 For DPP-4 Improves Net T2D Outcomes

Victoza bests Januvia for combo therapy on A1c, weight, hypoglycemia composite

<乌鸦传媒>How Sweet: Sugar Industry Made Fat the Villain

Harvard researchers received sugar industry money to write a NEJMreview

<乌鸦传媒>FDA Panel Splits on Expanded Jardiance Indication

Questions raised about key trial

<乌鸦传媒>Are Expensive Diabetes Drugs Worth It?

Jardiance and Victoza improve hard outcomes, but at a hefty cost

<乌鸦传媒>Mixed Findings on High Birth Weight, CV Risk Factors

Some markers of cardiovascular health better with high birth weight

<乌鸦传媒>Jardiance Shows Renal Benefit in EMPA-REG

Diabetes drug linked to slowing of kidney disease progression

<乌鸦传媒>Biosimilar Insulin Glargine Matches Up With Lantus in Phase III

Merck's copycat has similar HbA1c effect in trial

<乌鸦传媒>Survey: Diabetics Get Little Sympathy at Work

Co-workers give more slack to colleagues with other conditions

<乌鸦传媒>More Promising Results for Bionic Pancreas

But studies are short-term and relatively small

<乌鸦传媒>What's New in Beta Cell Transplantation

Gene editing, stem cells raise new possibilities

<乌鸦传媒>LEADER Trial Leads the Pack at ADA

But meeting in New Orleans will also feature thousands of new papers

<乌鸦传媒>Preventing Weight Gain in Special Needs Patients

Understanding risks, finding ways to cope

<乌鸦传媒>Canagliflozin Leads to Better A1c Control

Post-hoc analysis also finds lower risk of hypoglycemia

<乌鸦传媒>Obesity Guidelines Headline AACE 2016

First such guidelines in 25 year history

<乌鸦传媒>Vitamin D: Study Finds Impaired Fertility

Study highlights potential adverse effects of too much vitamin D

<乌鸦传媒>Long-Term Statin Use Linked to Complications in T2D Patients

But patients not matched at baseline

<乌鸦传媒>Blood Pressure Drop for CKD Patients on Patiromer

Sub-analyses finds those with resistant hypertension see benefits

<乌鸦传媒>Fanconi Syndrome Seen With Off-Label Canagliflozin

T1D patient presented 1 week after starting drug

<乌鸦传媒>CKD Patients With Diabetes Have Altered Gut Bugs

Presence of certain microbes could boost inflammation

<乌鸦传媒>NKF: Kidney Transplant Patients Face Diabetes Risk

Meta-analysis findings may impact clinical management and follow-up

<乌鸦传媒>Saxagliptin, Alogliptin Linked to Heart Failure, FDA Warns

Decision comes 1 year after FDA advisory committee vote

<乌鸦传媒>Whey Protein Tied to Weight Loss in T2D

Glucose levels also dropped with whey versus other protein-based diets

<乌鸦传媒>Why Did Afrezza Flop?

Patients don't hate needles that much, docs suggest

<乌鸦传媒>Antidepressant Use Tied to Better Diabetes Control

May reflect improved adherence to doctors' advice

<乌鸦传媒>Game-Changers in Cardiology: Jardiance Heart Benefit

A diabetes drug that benefits the heart

<乌鸦传媒>FDA Lifts Restriction On Rosiglitazone

Agency sees no need for restrictions after easing them 2 years ago

<乌鸦传媒>Early Weight Loss With Saxenda Predicts More

Conversely, initial nonresponse is typically maintained

<乌鸦传媒>Weight-Loss Surgery a Safe Option for Mildly Obese With T2D

Patients faced a 4.2% complication rate in 30 days

<乌鸦传媒>T1D Patients Face Nearly Double Risk for Dementia

Findings still significant after controlling for vascular risk factors.

<乌鸦传媒>GI Events Do Not Explain Weight Loss With Saxenda

No difference in weight loss between patients who had nausea and vomiting with diet drug, and those who didn't.

<乌鸦传媒>Three Diabetes Drugs Linked to Ketoacidosis, FDA Warns

FDA targets SGLT2 inhibitors canagliflozin, dapagliflozin, and empagliflozin.

<乌鸦传媒>Enzyme Rise May Link GLP-1, Pancreatitis

Levels of lipase and amylase don't increase after meals in patients not taking GLP-1 drugs.

<乌鸦传媒>TECOS Top Line: No Increase in CV Risk with DPP-4 Inhibitor

Primary and secondary endpoints met for those on sitagliptin.

鈥�

13